At present, despite the wealth of data indicating the prominent alterations of IL-33/IL1RL1 expression in the inflamed mucosa of IBD patients, no definitive data have demonstrated the precise role of this axis during gut inflammatory conditions. The gene discussed is IL1RL1; the disease is inflammatory bowel disease.